Results 171 to 180 of about 113,396 (305)

Antenatal Presentation of MRPS22‐Related Mitochondrial Disease Confirmed With Rapid Proteomics

open access: yesJIMD Reports, Volume 67, Issue 3, May 2026.
ABSTRACT MRPS22‐related mitochondrial disease (MIM#611719) is a rare autosomal recessive disorder caused by defects in the mitochondrial ribosomal protein S22, a component of the small mitoribosomal subunit essential for mitochondrial translation. Of the few reported cases, most present antenatally with a severe phenotype, conveying a poor prognosis ...
Liana N. Semcesen   +43 more
wiley   +1 more source

Fluorescent Light Energy in Feline Surgical and Traumatic Wounds: A Prospective Single‐Arm Pilot Study of Healing Progression and Bacterial Findings

open access: yesVeterinary Medicine and Science, Volume 12, Issue 3, May 2026.
Fluorescent light energy (FLE) is a safe and well‐tolerated strategy for feline wound management. In this study, its use resulted in a 73% improvement in TIME healing scores within 14 days. Notably, FLE significantly reduced inflammation and necrosis, even in wounds colonized by multidrug‐resistant bacteria.
Francesca Paola Nocera   +7 more
wiley   +1 more source

Investigation of Potential Risks in Bio‐Based Food Contact Materials (FCMs) From Microbial Exploitation of Agricultural Wastes: Case Studies of Bacterial Cellulose and Nisin

open access: yesComprehensive Reviews in Food Science and Food Safety, Volume 25, Issue 3, May 2026.
ABSTRACT In the context of the circular economy and the increasing demand for safe and sustainable packaging, this work addresses the safety assessment of food contact materials (FCMs) derived from agro‐industrial by‐products. Despite growing interest in these bio‐based materials, the literature still lacks a structured safety‐assessment framework able
Marianna Ciccone   +6 more
wiley   +1 more source

Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia.

open access: yesCell, 2001
M. Ridanpää   +12 more
semanticscholar   +1 more source

A quality improvement initiative to reduce inappropriate plasma transfusions across community hospitals in the Niagara region

open access: yesVox Sanguinis, Volume 121, Issue 5, Page 593-602, May 2026.
Abstract Background and Objectives Plasma transfusion is indicated for patients with coagulopathy and active bleeding or those undergoing major surgery. Appropriate use is defined by an international normalized ratio (INR) >1.7 and a dose of 3–4 units for adults.
Krista Walter   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy